DePuy Hip Replacement Recall
The complaints about defective hip implants made by DePuy Orthopaedics, Inc., a part of Johnson and Johnson’s Medical Devices & Diagnostics group, had been sending to the U.S. Food and Drug Administration over the past two years. On August 24, 2010, after a warning letter from the F.D.A. and the new medical information of these faulty hip implants from the UK National Joint Registry, DePuy finally recalled about 93,000 of these artificial joints. What are the ethical risks and consequences associated with DePuy’s products? What should DePuy do to correct these failures? DePuy Inc., a member of the Johnson & Johnson Family of Companies, a world leader in health care products and services, was founded in 1895. DePuy Inc. develops and markets products under the DePuy Orthopaedics, Inc.; DePuy Spine, Inc.; Codman & Shurtleff, Inc.; and DePuy Mitek units. DePuy Orthopaedics Inc. was the first commercial orthopaedics company in the U.S. To become a global leader in orthopaedic devices and supplies, the company has committed to the innovation in patient care and improvement of movement in patients’ lives around the world. DePuy Orthopaedics manufactures more than 200 of joint replacement products that include hip, knee, ankle, finger and shoulder, and operating room products. DePuy Orthopaedics, Inc. and its medical devices & diagnostics group have been developing their technologies, products and services, and addressing some of the most chronic and pervasive conditions, and continuing in their tradition of advancing the standard of healthcare and education, and new treatments and solutions. However, on August 24, 2010, DePuy Orthopaedics and J&J announced recall of two of DePuy hip replacement products, the ASR™ XL Acetabular System and the DePuy ASR™ Hip Resurfacing System. The DePuy ASR™ Hip Resurfacing System, a rounded bone atop the thigh bone that fits into that socket like a ball, was available outside the U.S. and the ASR™ XL...
Please join StudyMode to read the full document